🚀 Exciting News! 🌟 AlphaLife Sciences has been recognized as a Major Contender in the prestigious Everest Group’s 2024 PEAK Matrix® for Life Sciences Clinical Data and Analytics (D&A) Platforms!
CEO Sharon Chen showcased AlphaLife Sciences' AuroraPrime platform at Johnson & Johnson Innovation JLABS Summits, emphasizing GenAI-powered advancements in medical writing and accelerating drug development through streamlined clinical documentation.
Alice Hsu presented AI-powered clinical trials at DIA 2024, while CEO Sharon Chen shared strategic insights on innovative approaches as a panel expert.
AlphaLife Sciences CEO Sharon Chen attended Microsoft Build: AI Day in Bangkok, engaging with CEOs and Satya Nadella on advancing AI and cloud technology.